Intestinal Carcinoma — Trials

Intestinal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,268 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 409
Recruiting: 235
Ph III recruiting: 16
Growth YoY: +6%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (150)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01329809	Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors	terminated	Phase 2	2	Jennerex BiotherapeuticsINDUSTRY	1	Apr 10, 2013	clinicaltrials
NCT00405561	Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003	terminated	Phase 2 / Phase 3	67	Auron Healthcare GmbHINDUSTRY	1	Mar 20, 2013